Why Us2023-10-19T16:24:21+13:00

Complex chemistry into commercial success

We bring together world-class facilities, deep experience, a focus on solutions, and easy to navigate business processes.

Our partnerships with clients from NASDAQ Pharma companies to fast-growing biotech start-ups are transparent and high-trust.

We provide a niche offering in the middle of the drug development cycle, synthesising complicated bioactive molecules, and developing reliable and robust processes for manufacture.

What sets us apart:

Unparalleled expertise

We have a rich history of ground-breaking work with international partners on small-molecule enzyme inhibitors and synthetic vaccines. Our team is proud to be at the forefront of drug development for some of the world’s most serious diseases.

We support cGMP manufacturing by applying our exceptional expertise in R&D, synthetic route development, scale-up synthesis, and analytical method development to a range of pharmaceutical research areas.

Transparent Process

Our delivery of high-quality and fast-paced drug substance development and manufacture is second to none. We enable human proof-of-concept studies and more effective targeted treatments for some of the world’s major diseases.

While our field of work is incredibly complex, our working approach is very down-to-earth. Transparency and good communication are at the core of our relationships. We are serious about reporting to clients, giving you full oversight of your development projects all the way to manufacture.

State-of-the-art facilities

We can take you from milligrams to kilograms. Our custom-built cGMP facilities can manufacture active pharmaceutical ingredients (APIs) by chemical synthesis at multi-kilogram scale for use in pre-clinical and clinical trials.

Our niche is delivering molecules requiring intrinsically complex manufacturing requirements. We have specialist capabilities well suited to purifying carbohydrates and polymers. Our deep understanding of carbohydrate chemistry means we can easily handle cryogenic reactions and high-pressure conditions at scale.

What our clients say about us

“When GRO Biosciences was looking for a skilled partner in the synthetic carbohydrate chemistry space, we surveyed a number of firms.  Glycosyn offered us a blend of competence, creativity, and ease of interaction that keeps us coming back for more. 

What started as a single project has now grown into 5 projects across 30 months and counting.  We have dealt with a variety of team members at Glycosyn, all of whom bring strong expertise in their subject matter areas and a commitment to getting the job done.  Given the other partners that we diligenced for our projects, it simply wouldn’t be possible to do with them what we’re doing with Glycosyn.”

Christopher Gregg CSO, GRO Biosciences

“GlycoSyn not only have excellent facilities supported by world class staff but importantly from a client’s perspective, understand the pharmaceutical industry needs and demanding standards from laboratory work through to process design and scale up under GMP.

This, together with not only a “can do” but a “will do” attitude has significantly contributed to our ongoing success.”

Philip Marshall CEO, Oncology Research International Limited

“I’ve had the great fortune to work with GlycoSyn for over 10 years  on projects that span my time at Spinifex Pharmaceutical and Starpharma.

In all their work for me they have demonstrated a very high level of technical proficiency as they developed scalable synthetic routes to APIs and intermediates and executed cGMP campaigns. Their facility is first-class and is supported by an excellent analytical chemistry group and a robust quality assurance system.

What sets GlycoSyn apart is they do more than just ‘fee-for-service’ work; they commit to a project as if it were their own.”

Tom McCarthy CEO, Spinifex Pharmaceuticals

Some of our Success Stories

Go to Top